Stemline Therapeutics Switzerland GmbH

General information
Stemline Therapeutics Switzerland GmbH
Grafenaustrasse 3
6300 Zug, Zug (ZG)

Company main phone: +1 (646) 5022310
Year founded:2019
Source of foundation:Subsidiary
Name of foundation source:Stemline Therapeutics, Inc. (USA)
Corporate description / mission:
Stemline Therapeutics Switzerland GmbH is a subsidiary of Stemline Therapeutics Inc., a commercial-stage biopharmaceutical company focused on the development and commercialization of novel oncology therapeutics. The goal of Stemline Therapeutics is to build a leading biopharmaceutical company focused on improving the lives of cancer patients by developing and commercializing novel first-in-class therapeutics.
State of ownership: Private / independent
Headquarters: No
  • Biotechnology - Therapeutics and Diagnostics
  • Immunotherapy
  • Peptides
  • Small molecules
Primary therapeutic areas:
  • Neoplasms / cancer / oncology
Business model:
  • R&D
  • Subsidiary
Customer segments:
  • Hospitals
  • Large biotech & big pharma
  • Small biotech